Alerts will be sent to your verified email
Verify Email
EMMESSA
|
Emmessar Biotech&Nut
|
Colinz Laboratories
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.99 % | 4.71 % | 0.0 |
|
5yr average Equity Multiplier
|
1.23 | 1.29 | 1.02 |
|
5yr Average Asset Turnover Ratio
|
0.25 | 0.64 | 0.0 |
|
5yr Avg Net Profit Margin
|
77.44 % | 5.84 % | 0.0 |
|
Price to Book
|
1.5 | 1.21 | 10.25 |
|
P/E
|
36.63 | 23.55 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
63.13 Days | -11.59 Days | 0.0 |
|
Inventory Days
|
54.75 Days | 56.66 Days | 0.0 |
|
Days Receivable
|
11.98 Days | 42.5 Days | 0.0 |
|
Days Payable
|
169.78 Days | 89.1 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
820.35 | 11.55 | 0.0 |
|
5yr Avg ROCE
|
17.27 % | 6.71 % | -8.65 % |
|
5yr Avg Operating Profit Margin
|
-130.11 % | 7.54 % | 0.0 |
|
5 yr average Debt to Equity
|
0.0 | 0.07 | 0.0 |
|
5yr CAGR Net Profit
|
-26.08 % | 18.95 % | -15.95 % |
|
5yr Average Return on Assets
|
8.75 % | 3.68 % | -8.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.53 % | 66.0 % | 43.36 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.0 % | 0.0 | 0.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Emmessar Biotech&Nut
|
Colinz Laboratories
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|